If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Do-Youn Oh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 57 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Biliary Tract Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 8663 Citations
  • 43 h-Index
  • 274 Article
  • 7 Review article
  • 3 Comment/debate
  • 1 Editorial

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer

Park, H., Bang, J. H., Nam, A. R., Eun Park, J., Hua Jin, M., Bang, Y. J. & Oh, D-Y., 1 Dec 2019, In : Scientific Reports. 9, 1, 11131.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Pancreatic Neoplasms
Ligands
Drug Therapy
Disease Progression
Tumor Microenvironment

GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer

Park, J. E., Jin, M. H., Hur, M., Nam, A. R., Bang, J. H., Won, J., Oh, D-Y. & Bang, Y. J., 5 Sep 2019, In : Gastric Cancer. 22, 5, p. 932-940 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Stomach Neoplasms
Anti-Idiotypic Antibodies
Mutation
Cytotoxins
Ligands

Role of surgical resection in the era of FOLFIRINOX for advanced pancreatic cancer

Byun, Y., Han, Y., Kang, J. S., Choi, Y. J., Kim, H., Kwon, W. I., Kim, S. W., Oh, D-Y., Lee, S. H., Ryu, J. K., Kim, Y. T. & Jang, J-Y., 1 Sep 2019, In : Journal of Hepato-Biliary-Pancreatic Sciences. 26, 9, p. 416-425 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Pancreatic Neoplasms
Survival
Therapeutics
Multivariate Analysis
Guidelines

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study

Kim, J. W., Lee, K. H., Kim, J. W., Suh, K. J., Nam, A. R., Bang, J. H., Bang, Y. J. & Oh, D-Y., 13 Aug 2019, In : British Journal of Cancer. 121, 4, p. 332-339 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Biliary Tract Neoplasms
MAP Kinase Signaling System
Mutation
gemcitabine
Disease-Free Survival

Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial

Yoshikawa, T., Muro, K., Shitara, K., Oh, D-Y., Kang, Y. K., Chung, H. C., Kudo, T., Chin, K., Kadowaki, S., Hamamoto, Y., Hironaka, S., Yoshida, K., Yen, C. J., Omuro, Y., Bai, L. Y., Maeda, K., Ozeki, A., Yoshikawa, R. & Kitagawa, Y., 2 Aug 2019, In : JAMA network open. 2, 8, p. e198243

Research output: Contribution to journalArticleResearchpeer-review

Open Access
oxaliplatin
Far East
Paclitaxel
Stomach Neoplasms
Randomized Controlled Trials